XORTX Therapeutics Inc. (XRTX)

NASDAQ: XRTX · Real-Time Price · USD

1.110

+0.060 (5.71%)

At close: Apr 23, 2025, 4:00 PM

1.090

-0.020 (-1.80%)

Pre-market: Apr 24, 2025, 8:09 AM EDT

XORTX Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	2.19	2.28	1.93	1.22	0.51	Upgrade
Research & Development	0.18	2.42	6.76	0.68	0.28	Upgrade
Operating Expenses	2.62	4.96	9.24	2.31	1.1	Upgrade
Operating Income	-2.62	-4.96	-9.24	-2.31	-1.1	Upgrade
Interest Expense	-	-	-	-0	-0.01	Upgrade
Interest & Investment Income	0.12	0.25	0.1	-	-	Upgrade
Currency Exchange Gain (Loss)	-0.07	-0.01	-0	-0.01	0	Upgrade
Other Non Operating Income (Expenses)	-0.75	2.55	1.42	0.75	-0.2	Upgrade
EBT Excluding Unusual Items	-3.31	-2.16	-7.72	-1.58	-1.31	Upgrade
Asset Writedown	-	-	-	-	-0.06	Upgrade
Other Unusual Items	-	-	-	-	0.09	Upgrade
Pretax Income	-3.31	-2.16	-7.72	-1.58	-1.28	Upgrade
Net Income	-3.31	-2.16	-7.72	-1.58	-1.28	Upgrade
Net Income to Common	-3.31	-2.16	-7.72	-1.58	-1.28	Upgrade
Shares Outstanding (Basic)	3	2	1	1	1	Upgrade
Shares Outstanding (Diluted)	3	2	1	1	1	Upgrade
Shares Change (YoY)	45.25%	33.91%	35.25%	47.77%	24.34%	Upgrade
EPS (Basic)	-1.15	-1.09	-5.22	-1.44	-1.73	Upgrade
EPS (Diluted)	-1.15	-1.09	-5.22	-1.44	-1.73	Upgrade
Free Cash Flow	-3.68	-6.59	-8.19	-4.8	-0.73	Upgrade
Free Cash Flow Per Share	-1.28	-3.32	-5.53	-4.39	-0.98	Upgrade
EBITDA	-2.58	-4.88	-9.22	-2.3	-1.08	Upgrade
D&A For EBITDA	0.04	0.07	0.02	0.01	0.02	Upgrade
EBIT	-2.62	-4.96	-9.24	-2.31	-1.1	Upgrade

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q